Literature DB >> 25583851

Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.

Daniel M Harrison1, Jiwon Oh2, Snehashis Roy3, Emily T Wood4, Anna Whetstone2, Michaela A Seigo2, Craig K Jones5, Dzung Pham3, Peter van Zijl6, Daniel S Reich7, Peter A Calabresi2.   

Abstract

OBJECTIVE: Pathology in both cortex and deep gray matter contribute to disability in multiple sclerosis (MS). We used the increased signal-to-noise ratio of 7-tesla (7T) MRI to visualize small lesions within the thalamus and to relate this to clinical information and cortical lesions.
METHODS: We obtained 7T MRI scans on 34 MS cases and 15 healthy volunteers. Thalamic lesion number and volume were related to demographic data, clinical disability measures, and lesions in cortical gray matter.
RESULTS: Thalamic lesions were found in 24/34 of MS cases. Two lesion subtypes were noted: discrete, ovoid lesions, and more diffuse lesional areas lining the periventricular surface. The number of thalamic lesions was greater in progressive MS compared to relapsing-remitting (mean ±SD, 10.7 ±0.7 vs. 3.0 ±0.7, respectively, p < 0.001). Thalamic lesion burden (count and volume) correlated with EDSS score and measures of cortical lesion burden, but not with white matter lesion burden or white matter volume.
CONCLUSIONS: Using 7T MRI allows identification of thalamic lesions in MS, which are associated with disability, progressive disease, and cortical lesions. Thalamic lesion analysis may be a simpler, more rapid estimate of overall gray matter lesion burden in MS.
© The Author(s), 2015.

Entities:  

Keywords:  MRI; multiple sclerosis

Mesh:

Year:  2015        PMID: 25583851      PMCID: PMC4499502          DOI: 10.1177/1352458514558134

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  35 in total

Review 1.  The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.

Authors:  J S Fischer; R A Rudick; G R Cutter; S C Reingold
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

2.  Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

Authors:  Yawei Liu; Ingrid Teige; Bryndis Birnir; Shohreh Issazadeh-Navikas
Journal:  Nat Med       Date:  2006-04-23       Impact factor: 53.440

3.  Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Authors:  R Rudick; J Antel; C Confavreux; G Cutter; G Ellison; J Fischer; F Lublin; A Miller; J Petkau; S Rao; S Reingold; K Syndulko; A Thompson; J Wallenberg; B Weinshenker; E Willoughby
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

4.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

Authors:  Lars Bö; Jeroen J G Geurts; Paul van der Valk; Chris Polman; Frederik Barkhof
Journal:  Arch Neurol       Date:  2007-01

5.  Regional lobar atrophy predicts memory impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov; Dominic A Carone; Bianca Weinstock-Guttman; Jeff Gaines; Cosimo Maggiore; Jitendra Sharma; Maria-Antonietta Tomassi; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

6.  Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

Authors:  Luisa M Villar; María C Sádaba; Ernesto Roldán; Jaime Masjuan; Pedro González-Porqué; Noelia Villarrubia; Mercedes Espiño; José A García-Trujillo; Alfredo Bootello; José C Alvarez-Cermeño
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.

Authors:  Jeroen J G Geurts; Petra J W Pouwels; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof; Jonas A Castelijns
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

8.  Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Authors:  Alexandra Kutzelnigg; Claudia F Lucchinetti; Christine Stadelmann; Wolfgang Brück; Helmut Rauschka; Markus Bergmann; Manfred Schmidbauer; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

9.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

10.  MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis.

Authors:  Jeroen J G Geurts; Ilona E W Reuling; Hugo Vrenken; Bernard M J Uitdehaag; Chris H Polman; Jonas A Castelijns; Frederik Barkhof; Petra J W Pouwels
Journal:  Magn Reson Med       Date:  2006-03       Impact factor: 4.668

View more
  21 in total

Review 1.  Perspectives of Ultra-High-Field MRI in Neuroradiology.

Authors:  E R Gizewski; C Mönninghoff; M Forsting
Journal:  Clin Neuroradiol       Date:  2015-07-17       Impact factor: 3.649

2.  White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis.

Authors:  Vincent Planche; Jason H Su; Sandy Mournet; Manojkumar Saranathan; Vincent Dousset; May Han; Brian K Rutt; Thomas Tourdias
Journal:  Mult Scler       Date:  2019-02-07       Impact factor: 6.312

Review 3.  Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.

Authors:  Matilde Inglese; Lazar Fleysher; Niels Oesingmann; Maria Petracca
Journal:  Expert Rev Neurother       Date:  2018-01-30       Impact factor: 4.618

Review 4.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

5.  Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study.

Authors:  Niels Bergsland; Ferdinand Schweser; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov
Journal:  Hum Brain Mapp       Date:  2018-06-19       Impact factor: 5.038

6.  Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.

Authors:  Christina J Azevedo; Steven Y Cen; Sankalpa Khadka; Shuang Liu; John Kornak; Yonggang Shi; Ling Zheng; Stephen L Hauser; Daniel Pelletier
Journal:  Ann Neurol       Date:  2018-02-09       Impact factor: 10.422

7.  Structural correlates for fatigue in early relapsing remitting multiple sclerosis.

Authors:  Janine Wilting; Hans O Rolfsnes; Hilga Zimmermann; Marion Behrens; Vinzenz Fleischer; Frauke Zipp; Adriane Gröger
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

Review 8.  Magnetic Resonance Imaging in Multiple Sclerosis.

Authors:  Christopher C Hemond; Rohit Bakshi
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

9.  Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI.

Authors:  Ambica Mehndiratta; Constantina A Treaba; Valeria Barletta; Elena Herranz; Russell Ouellette; Jacob A Sloane; Eric C Klawiter; Revere P Kinkel; Caterina Mainero
Journal:  Mult Scler       Date:  2020-06-25       Impact factor: 6.312

10.  Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.

Authors:  Kedar R Mahajan; Kunio Nakamura; Jeffrey A Cohen; Bruce D Trapp; Daniel Ontaneda
Journal:  Ann Neurol       Date:  2020-05-01       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.